“The benefit of this incremental cavity protection … is something that we will build upon,” says CMO Nigel Burton. The firm seeks to build the Colgate Maximum Cavity Protection brand in emerging markets, where consumers struggle with cavities due to a lack of fluoride in water.
Colgate Maximum Cavity Protection with Neturazucar is a “long-term innovation platform” for the brand to provide products that deliver “incremental cavity protection,” says Colgate-Palmolive Co. executive Nigel Burton.
At the UBS Global Consumer Conference in Boston on March 13, Burton said the arginine-containing toothpaste rolled out in late...
The 14 July deadline for the Citeline Japan Awards 2025 in Tokyo is approaching fast, so here's a reminder to take a look at the categories and criteria and be sure to get your submissions in by this date. Sponsorship opportunities and tables for the event are also available.
While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.
Japan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi.
Japan's NHI program continues to give and take as 11 new drugs are granted reimbursement, while the prices of others - including three ophthalmic therapies - are cut by up to 20% under a Market Expansion Repricing scheme.
Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.
At this year’s DIA China meeting, the national regulator updated its policy focus areas for this year, including clinical trial data protection and pilot projects to shorten IND approval times.
Japan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi.
